Ad5-Δ24-GMCSF, an oncolytic adenovirus engineered to express GMCSF, which recruits NK cells and induces tumor-specific T-cell responses, was evaluated in 20 patients with advanced refractory solid tumors (including 4 EOC) [70]. The gene discussed is CSF2; the disease is neoplasm.